Live event: Thursday 19 October 2017 at 07:00 [PDT] 10:00 [EDT] 15:00 [BST]
We want to assess and mitigate risk from pre-existing antibodies early within clinical development. Will pre-existing antibodies impact our clinical trial?
Live event: Thursday 12 October 2017 at 07:00 [PDT] 10:00 [EDT] 15:00 [BST]
Gain first-hand experience from a CRO on their transition from small molecule bioanalysis to biologics.
Available to view on demand: In this webinar, Glenn Petrie discusses best practice in optimizing the Chemistry, Manufacturing and Control (CMC) process.
Live event: Tuesday 3 October 2017 at 07:00 [PDT] 10:00 [EDT] 15:00 [BST]
This webinar will explore this continuum of fit-for-purpose validation, from the validation of early exploratory biomarker analysis, to the amalgamation of FDA GLP and CLIA GLP biomarker validation guidelines in the bioanalytical lab.
Available to view on demand: In this webinar, Kenneth Brouwer outlines the initiating events and the hepatocyte’s response in the regulation of bile acids.
In this webinar Kyunghee Yang and Kenneth Brouwer outline the species differences in the hepatobiliary disposition and regulation of bile acids.
Live event: Thursday, Oct 5, 2017 5:00 PM – 6:00 [BST].
In this webinar, James Schmidt discusses stereo-selectivity in drug metabolism.
Live event: Thursday 5 October 2017 at 08:00 [PDT] 11:00 [EDT] 16:00 [BST]
Experts in microsampling share their knowledge and experience of what is required to complete a successful implementation, with insights for anyone struggling with a new and disruptive technology.
Available on demand
Altasciences’ experts share their most recent experience using Volumetric Absorptive Microsampling Mitra™ technology from product characterization to application development, highlighted with specific case studies.
Live event: Tuesday 31 October 2017 at 07:00 [PDT] 10:00 [EDT] 14:00 [BST]
In this presentation, the results of an exploration of HRMS for the quantitative determination of biopharmaceutical proteins and a comparison to nominal mass LC-MS/MS will be provided, including validation results and application to preclinical trials.